Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BABAK RAJABI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1194986794
CMS profile
144872
Location
CARMICHAEL, CA

General Payments · PY2018–2024

$11,625.37

  • Reported across 271 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,853.53

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $1,096.70 11
Food and Beverage $779.53 38
Consulting Fee $525.00 1
Education $452.30 5

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,034.44 22
PY2019 $1,510.94 77
PY2020 $3,654.68 15
PY2021 $920.95 30
PY2022 $504.93 29
PY2023 $1,145.90 43
PY2024 $2,853.53 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $34.19 07/29/2024 Food and Beverage Undisputed 01/23/2026 1105357042 CMS
ABBVIE INC. $24.97 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105357046 CMS
Agios Pharmaceuticals, Inc. $25.72 12/11/2024 Food and Beverage Undisputed 01/23/2026 1149644255 CMS
ARRAY BIOPHARMA INC $28.01 08/06/2024 Food and Beverage Undisputed 01/23/2026 1131815158 CMS
ARRAY BIOPHARMA INC $9.14 12/21/2024 Food and Beverage Undisputed 01/23/2026 1131440307 CMS
Astellas Pharma US Inc $19.21 01/11/2024 Food and Beverage Undisputed 01/23/2026 1139290098 CMS
Astellas Pharma US Inc $16.31 04/08/2024 Food and Beverage Undisputed 01/23/2026 1139335806 CMS
Astellas Pharma US Inc $23.15 07/22/2024 Food and Beverage Undisputed 01/23/2026 1139271724 CMS
Astellas Pharma US Inc $99.95 08/30/2024 Education Undisputed 01/23/2026 1139408257 CMS
AstraZeneca Pharmaceuticals LP $78.38 02/05/2024 Food and Beverage Undisputed 01/23/2026 1104530056 CMS
AstraZeneca Pharmaceuticals LP $16.38 04/22/2024 Food and Beverage Undisputed 01/23/2026 1105549473 CMS
AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1105204756 CMS
AstraZeneca Pharmaceuticals LP $13.35 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104518140 CMS
AstraZeneca Pharmaceuticals LP $13.83 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105574146 CMS
AstraZeneca Pharmaceuticals LP $16.90 12/09/2024 Food and Beverage Undisputed 01/23/2026 1104265629 CMS
BeiGene USA, Inc. $13.16 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120852625 CMS
Celgene Corporation $16.25 11/18/2024 Food and Beverage Undisputed 01/23/2026 1101135362 CMS
E.R. Squibb & Sons, L.L.C. $18.19 01/04/2024 Food and Beverage Undisputed 01/23/2026 1101426114 CMS
E.R. Squibb & Sons, L.L.C. $20.78 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101426122 CMS
E.R. Squibb & Sons, L.L.C. $17.95 09/23/2024 Food and Beverage Undisputed 01/23/2026 1101426142 CMS
E.R. Squibb & Sons, L.L.C. $14.75 09/23/2024 Food and Beverage Undisputed 01/23/2026 1101426144 CMS
Eisai Inc. $22.08 02/27/2024 Food and Beverage Undisputed 01/23/2026 1110732526 CMS
Eisai Inc. $52.50 06/26/2024 Education Undisputed 01/23/2026 1110732528 CMS
Genentech USA, Inc. $30.68 05/13/2024 Food and Beverage Undisputed 01/23/2026 1132980197 CMS
Genmab U.S., Inc. $22.61 08/02/2024 Food and Beverage Undisputed 01/23/2026 1126824661 CMS
GlaxoSmithKline, LLC. $16.77 01/06/2024 Food and Beverage Undisputed 01/23/2026 1115906445 CMS
Incyte Corporation $99.95 05/13/2024 Education Undisputed 01/23/2026 1141293710 CMS
Janssen Biotech, Inc. $36.51 11/26/2024 Food and Beverage Undisputed 01/23/2026 1078290055 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310391 CMS
Novartis Pharmaceuticals Corporation $16.47 03/12/2024 Food and Beverage Undisputed 01/23/2026 1087310341 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310393 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310395 CMS
Novartis Pharmaceuticals Corporation $31.55 04/24/2024 Food and Beverage Undisputed 01/23/2026 1087310355 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310397 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310399 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310401 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310387 CMS
Novartis Pharmaceuticals Corporation $26.35 09/25/2024 Food and Beverage Undisputed 01/23/2026 1087310407 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310389 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310415 CMS
Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310413 CMS
Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087310429 CMS
PFIZER INC. $99.95 01/30/2024 Education Undisputed 01/23/2026 1131472755 CMS
PFIZER INC. $99.95 03/11/2024 Education Undisputed 01/23/2026 1131472763 CMS
PFIZER INC. $13.59 04/16/2024 Food and Beverage Undisputed 01/23/2026 1131309996 CMS
PFIZER INC. $23.43 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131414141 CMS
PFIZER INC. $2.20 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131898777 CMS
PFIZER INC. $0.96 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131898779 CMS
PFIZER INC. $14.69 04/30/2024 Food and Beverage Undisputed 01/23/2026 1131325036 CMS
PFIZER INC. $14.07 05/01/2024 Food and Beverage Undisputed 01/23/2026 1131472759 CMS
PFIZER INC. $16.04 06/03/2024 Food and Beverage Undisputed 01/23/2026 1131346440 CMS
PFIZER INC. $10.70 08/01/2024 Food and Beverage Undisputed 01/23/2026 1131367064 CMS
PFIZER INC. $25.20 08/19/2024 Food and Beverage Undisputed 01/23/2026 1131343588 CMS
SERVIER PHARMACEUTICALS LLC $21.82 07/16/2024 Food and Beverage Undisputed 01/23/2026 1147258324 CMS
Stemline Therapeutics Inc. $13.19 05/17/2024 Food and Beverage Undisputed 01/23/2026 1142958512 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.